BEUDAMED
    FDA Adverse Event Injury Summary report: N

    ENDURANT STENT GRAFT

    MDR report key: 10598467 · Received September 29, 2020

    Report

    Report Number
    9612164-2020-03663
    Event Type
    Injury
    Date Received
    September 29, 2020
    Date of Event
    December 18, 2019
    Report Date
    September 29, 2020
    Manufacturer
    MEDTRONIC IRELAND
    Product Code
    MIH
    PMA / PMN Number
    P100021
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    JA
    Reporter Occupation
    PHYSICIAN

    Narratives

    Additional Manufacturer Narrative · 1

    MEDTRONIC RECEIVED THE FOLLOWING INFORMATION FROM A JOURNAL ARTICLE ENTITLED; ENDOVASCULAR AORTIC ANEURYSM REPAIR WITHOUT TYPE 2 ENDOLEAK USING CONCOMITANT N-BUTYL-2-CYANOACRYLATE INJECTION INTO THE ABDOMINAL AORTIC ANEURYSM SAC MIURA S, KURIMOTO Y, MARUYAMA R, MASUDA T, YANASE Y, IBA Y, NOJIMA M <(>&<)> YAMADA A. ANNALS OF VASCULAR SURGERY 2020; 66: 110¿119 HTTPS://DOI.ORG/10.1016/J.AVSG.2019.12.006. (B)(4). IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

    Description of Event or Problem · 1

    ENDURANT STENT GRAFTS AND NON MDT STENT GRAFTS WERE IMPLANTED IN THE ENDOVASCULAR TREATMENT OF ABDOMINAL AORTIC ANEURYSMS. THE FOLLOWING MALFUNCTIONS WERE OBSERVED; TYPE IB ENDOLEAK, TYPE II ENDOLEAK THE FOLLOWING ADVERSE EVENTS WERE OBSERVED; RUPTURE, ACCESS ARTERY INJURY, RENAL FAILURE, OCCLUSION, LYMPHOCELE, ANEURYSM SAC ENLARGEMENT <(>&<)> RE-INTERVENTION PATIENT DEATHS WERE ALSO REPORTED BUT THERE IS NO CAUSAL LINK THAT THE ENDURANT STENT GRAFTS CAUSED OR CONTRIBUTED TO THESE DEATHS.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1064299 ENDURANT STENT GRAFT SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH MEDTRONIC IRELAND UNK-CV-SR-ENDURANT

    Patients

    Seq Age Sex Outcome Treatment
    1 76 YR Required Intervention